ur first batch of genetic data is available, and the quality is outstanding, indicating the sample collection protocol is robust. Since most ACAD participants are immigrants, immigration experience (languages, education, occupation transitions) could be a unique feature in disease development. Analyzing lifestyle data highlights the importance of the environment in AD risks and how genetics may interact with major life transitions.
News
ACAD investigator, Dr. Li-San Wang, presented at the Illuminating Alzheimer’s Disease Genetic Architecture via Diversity webinar. The program explored the lack of genome research for Black, Latino, and Asian populations while highlighting the organizations fighting for more. Dr. Wang discussed the need for more research infrastructure to study AD in Asian Americans and Pacific Islanders […]
In high school, Tiffany Chow was granted early admission to the accelerated Wharton School of Business MBA program. She discovered, however, that the ethics and humanity of Medicine would be a more compelling draw. Now, she’s coming full circle back to Penn as a new Professor of Pathology and Laboratory Medicine in the Associated Faculty, Adjunct Track, associated with her work for the Asian Cohort for Alzheimer’s Disease Study (ACAD).
We have received a $40.5M grant from the National Insitute of Aging (NIA) that will fund our research for the next five years. As of May 2023, more than 1,800 individuals have joined the interest list for the study, with 713 formally consented to enroll. The new grant aims to expand enrollment and recruit at […]
The Asian Cohort for Alzheimer’s Disease (ACAD) is pleased to announce a partnership with National Centralized Repository for Alzheimer’s Disease and Related Dementias (NCRAD) to analyze biosamples collected through ACAD sites.
CARE, COMPASS, and ACAD Joint Statement May 16, 2022 We are disheartened by the recent mass shootings fueled by hate across our country. This public health epidemic of hate-based shootings requires interventions at all levels especially structural, and we call on all to work collaboratively to combat this serious issue.
Collaborative Approach for AAPIs Research and Education (CARE), a research recruitment registry, employs community based participatory research methods that are culturally/linguistically appropriate.
This past June, the U.S. Food and Drug Administration approved Aduhelm (aducanumab) for the treatment of Alzheimer’s disease via an Accelerated Approval pathway.
ACAD stands against anti-Asian hate. Please read through the following article for links to the ACAD statement and statements from the ACAD members’ institutions and projects.
ACAD releases a statement addressing the tragedy in Atlanta that occurred on March 16, 2021